0.5 CME. Many patients with Lyme disease develop neurological complications from the infection. This presentation focuses on small fiber neuropathy secondary to Lyme disease. It also discusses immune mechanisms implicated in the post-treatment Lyme disease syndrome (PTLDS) and reduced cerebral blood flow as a potential etiology for the cognitive complaints that are common in patients with PTLDS.

0.5 CME. Many clinicians based diagnostic decisions on their assessment as to the likelihood that a patient has Lyme disease. Most consider epidemiologic data that is derived from surveillance case reports. However, this may underestimate risk for patients that reside in what has been considered traditionally low incidence states. This presentation documents the changing geographic demographics of the illness and clinicians in some areas of the country may need to reconsider how they assess a patient’s risk of Lyme disease.

1.0 CME. This presentation provides physicians with clinically useful information that will help them assist patients with ongoing manifestations of Lyme disease following antibiotic therapy for Lyme disease.

0.25 CME. For blacklegged tick bites, you will learn general management principles and how to distinguish asymptomatic and symptomatic bites.

0.5 CME. This module reviews the basic laboratory medicine principles of diagnostic testing.

1.0 CME. This presentation provides physicians with clinically useful information that will help them assist patients with known blacklegged tick bites.

1.0 CME. This presentation provides physicians with clinically relevant information that will enhance their diagnostic and management skills.

1.0 CME. This module discusses how clinicians may use serologic results in their diagnostic decision-making.

1.0 CME. Lyme carditis is a serious and sometimes fatal manifestation of the infection.

1.0 CME. This presentation provides physicians with clinically useful information that will help them assist patients with known blacklegged tick bites.

0.5 CME. This presentation covers the changing epidemiology of Lyme disease and the clinical applications of surveillance data.